ATRECA INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ATRECA INC and buy or sell other stocks, ETFs, and their options commission-free!

About BCEL

Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. 

CEO
John A. Orwin, MBA
CEOJohn A. Orwin, MBA
Employees
—
Employees—
Headquarters
San Carlos, California
HeadquartersSan Carlos, California
Founded
2010
Founded2010
Employees
—
Employees—

BCEL Key Statistics

Market cap
3.57M
Market cap3.57M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
—
Dividend yield—
Average volume
49.90K
Average volume49.90K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$1.18
52 Week high$1.18
52 Week low
$0.052
52 Week low$0.052

People also own

Based on the portfolios of people who own BCEL. This list is generated using Robinhood data, and it’s not a recommendation.
Nikola
Workhorse
Tilray Brands
Ideanomics
Plug Power
Camber Energy
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.